Zdrowie i gospodarka · 14/01/2014

FDA Releases Draft Guidance on Postmarketing Submissions of Interactive Promotional Media for Prescription Drugs and Biologics

The Food and Drug Administration (FDA) has released a draft guidance document titled "Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics," which provides industry-specific guidance on submitting interactive promotional media for approved prescription drugs and biologics. The document aims to clarify the FDA's policies on interactive promotional media.